Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
BackgroundBladder cancer (BLCA) is a common urinary system malignancy with a significant morbidity and death rate worldwide.Non-muscle invasive BLCA accounts for over 75% of all BLCA cases.The imbalance of tumor metabolic pathways is associated with tumor formation and proliferation.Pyrimidine metabolism (PyM) is a complex enzyme network that incor